Sartar Therapeutics
PrivateLast Round
Early Funding
Oct 1, 2025
Est. Valuation
$15.59M
Total Funding Raised
$9.36M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sartar Therapeutics is a pharmaceutical company that develops precision cancer treatments for gastrointestinal stromal tumors and other soft tissue sarcomas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sartar Therapeutics Comparables
Compare Sartar Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GSK plc | 74% | |
| Amira Therapeutics | 74% | |
| Degron Therapeutics | 72% | |
Sartar Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 1, 2025 | ||||
| Debt | Sep 20, 2021 | ||||
| Seed | Oct 19, 2020 |
Key People
Founding team and executive leadership
Sartar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Excedea Capital | Early Funding |
| Business Finland | Debt |
| Health Incubator Helsinki | Seed |
| NOME | Seed |
| Springvest | Early Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 961% MoM, from 67 to 711.
- Feb 14, 2026
Grew 75% QoQ from 4 to 7 employees.
Sartar Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sartar Therapeutics's valuation, stock price, and market status.